Sepsis Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The sepsis therapeutics market is segmented by Drug Class (Aminoglycosides, Cephalosporin, Glycopeptide Antibiotics, Others), Route of Administration, and Geography.

Market Snapshot

CAGR
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 7.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The sepsis therapeutics market is projected to register a CAGR of 7.6% over the forecast period. The major factor attributing to the growth of the market is the rising incidence of sepsis globally. According to the World Health Organization, it is estimated to affect more than 30 million people worldwide every year, potentially leading to 6 million deaths. The burden of sepsis is most likely the highest in the low- and middle-income countries. Furthermore, increasing research and development programs and funding are the factors boosting the market's growth.

However, the lack of initial diagnostic test for identifying sepsis conditions and the lack of awareness about the treatment are the factors constraining the market's growth.

Scope of the Report

As per the scope of the report, sepsis occurs when the body’s response to an infection injures its own tissues and organs, potentially leading to death or significant morbidity This report is segmented by drug class, route of administration, and geography.

By Drug Class
Aminoglycosides
Cephalosporin
Glycopeptide Antibiotics
Other Drug Classes
By Route of Administration
Intravenous
Oral
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Cephalosporins Dominate the Sepsis Therapeutics Market

The dominant share of the segment is attributed to the vast usage of the drug class, individually or in combination with the other drugs.

Cephalosporins are divided into the first, second, third, and fourth generation. First-generation cephalosporins have greater activity against gram-positive bacteria. The succeeding generations have increased activity against gram-negative bacteria and decreased activity against gram-positive bacteria.

Apart from the advantages and broad-spectrum activity of cephalosporins, the increasing incidence of sepsis is expected to boost the segment's growth.

Annual Incidence of Sepsis in million

North America Dominates the Market and Expected to do Same in the Forecast PeriodNorth America is expected to dominate the overall sepsis therapeutics market, throughout the forecast period. The largest share is mainly due to presence of larger patient pool and increasing geriatric population. Furthermore, well-established insurance policies and the availability of advanced healthcare infrastructure are few of the other factors boosting the market in this region. In North America region, the United States holds the largest market share due to the factors such as increasing number of geriatric populations, along with a growing number of patient pool in the country. According to Sepsis.org., more than 1.7 million people in the country are diagnosed with sepsis each year, one every 20 seconds and the incidence is rising 8% every year and the cost of hospitalization in the U.S. consuming more than USD 27 billion each year. As per the statistics the large patient pool and high disposable income propels the market growth in the region.

North America is expected to dominate the overall sepsis therapeutics market, throughout the forecast period. The largest share is mainly due to the presence of larger patient pool and increasing geriatric population. Furthermore, well-established insurance policies and the availability of advanced healthcare infrastructure are few of the other factors boosting the market in this region. In North America region, the United States holds the largest market share due to the factors such as increasing number of geriatric populations, along with a growing number of patient pool in the country. According to Sepsis.org., more than 1.7 million people in the country are diagnosed with sepsis each year, one every 20 seconds and the incidence is rising 8% every year and the cost of hospitalization in the U.S. consuming more than USD 27 billion each year. As per the statistics the large patient pool and high disposable income propels the market growth in the region.

Sepsis Therapeutics Market - Growth Rate by Region

Competitive Landscape

The sepsis therapeutics market is moderately competitive. A few of the crucial approaches followed by players are product development, invention, acquisitions, and mergers. Some of the companies currently dominating the market are F. Hoffmann-La Roche Ltd, Pfizer Inc., GlaxoSmithKline Inc., Mylan NV, and Allergan Inc.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence of Sepsis

      2. 4.2.2 Increasing Geraiatric Poulation

      3. 4.2.3 Rise in the Number of Pipeline Products and Upsurge in Research and Development Expenditures

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Initial Diagnostic Test for identifying Sepsis Conditions and Lack of Awareness

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Drug Class

      1. 5.1.1 Aminoglycosides

      2. 5.1.2 Cephalosporin

      3. 5.1.3 Glycopeptide Antibiotics

      4. 5.1.4 Other Drug Classes

    2. 5.2 By Route of Administration

      1. 5.2.1 Intravenous

      2. 5.2.2 Oral

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 F. Hoffmann-La Roche Ltd

      2. 6.1.2 Pfizer Inc.

      3. 6.1.3 GlaxoSmithKline Inc.

      4. 6.1.4 Mylan NV

      5. 6.1.5 Allergan Inc.

      6. 6.1.6 Asahi Kasei Corporation

      7. 6.1.7 RegeneRx

      8. 6.1.8 Inotrem SA

      9. 6.1.9 Endacea Inc.

      10. 6.1.10 Adrenomed AG

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Sepsis Therapeutics Market market is studied from 2018 - 2026.

The Sepsis Therapeutics Market is growing at a CAGR of 7.6% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

F. Hoffmann-La Roche Ltd, Pfizer Inc., GlaxoSmithKline Inc, Mylan N.V. , Allergan, Inc. are the major companies operating in Sepsis Therapeutics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!